Light Ai Inc. · NEO:ALGO
Light Ai — Investor Presentation (September 2025)
14 slides from Light Ai's investor presentation, September 2025
Slide 1: Detecting Infectious Diseases Instantly
Detecting Infectious Diseases Instantly Applying AI to smartphone images to identify disease in seconds – a patented, app-based software solution Leading the Digital Health Paradigm Shift Corporate Presentation September 2025 Confidential - Property of Light AI Inc. CBOE CA: ALGO FSE: 0HC OTCQB: OHCF
Slide 2: Disclaimer
Disclaimer This corporate presentation of Light AI Inc. (the “Company”) and the information contained actual results may differ materially from those in the forward-looking statements. Readers are reliance on forward-looking statements due to the inherent uncertainty therein. All herein (the “Presen
Slide 3: Leading the Digital Health Paradigm Shift
Leading the Digital Health Paradigm Shift Patented AI Platform to Detect Infectious Diseases by analyzing Smartphone Images in Seconds AI MEDICAL CONDITION DETECTION SOLUTION SIMPLE TO USE WITH FAST RESULTS • Accurate • AI Platform detection of Strep A, Covid, Conjunctivitis • UI friendly smartphone
Slide 4: The Problem and The Solution: Your Phone, Your Lifeline
Leading the Digital Health Paradigm Shift Patented AI Platform to Detect Infectious Diseases by analyzing Smartphone Images in Seconds The Problem: The Solution: Trillion Dollar Crisis Your Phone, Your Lifeline As reliable • 600 million people infected by Viral and Group A Streptococcus (GAS) pharyn
Slide 5: Existing Medical Ecosystem Time Consuming, Expensive, Inaccurate and Inefficient
Leading the Digital Health Paradigm Shift Existing Medical Ecosystem Time Consuming, Expensive, Inaccurate and Inefficient Current Medical Diagnostics 24-72+ Hours System Lab Test Lab Results Follow-Up Visit Treatment Plan Health Care Provider Patient’s specimen sent Additional time required to test
Slide 6: How it works: Identifies Infection within Seconds
Leading the Digital Health Paradigm Shift How it works: Identifies Infection within Seconds Contact Healthcare Scan Session Initiated Scan Analysis On-Demand Provider Patient is prompted to Light AI immediately Decision support that is Patient and healthcare scan their throat. Light AI analyzes the
Slide 7: Addressing Major Unmet Needs for Strep A and other Infectious Diseases
Leading the Digital Health Paradigm Shift Addressing Major Unmet Needs for Strep A and other Infectious Diseases NEED FOR URGENCY Strep A requires timely test results due to the potential health implications and the urgent need for treatment INACCURATE RESULTS Doctor unable to identify Strep A throu
Slide 8: An Iteratively Improving AI Model
An Iteratively Improving AI Model Multiple Pre-Regulatory Validation Studies Im age Data Base ~60,000 Im age Data Base ~50,000 100 Accuracy Accuracy 97% Im age Data Base ~40,000 94% Accuracy 89% 90 96.57% Current Accuracy Im age Data Base ~30,000 Accuracy 79% 80 Achieved 100% NPV (Negative Predictiv
Slide 9: Robust Patent Portfolio
Leading the Digital Health Paradigm Shift Robust Patent Portfolio Patent US11369318B2 Image processing of Patent EP3864669 streptococcal infection in pharyngitis subjects Image processing of streptococcal infection in pharyngitis subjects United States European Union (June 2022) (Dec 2024) Patent US
Slide 10: Anticipated Milestones
Anticipated Milestones 2025 2026 2027 Q3 Q4 Q1 Q2 Q3 Q4 Q1 Product v1 General Release Initial Commercialization Commercialization Wellness Professional Product v1 Product v1 Regulatory Regulatory Submission Approval Health Health Canada Canada (Class II) (Class III) Africa Regulatory India Regulator
Slide 11: Experienced Leadership
Experienced Leadership Management Extensive Peter Whitehead CEO, Founder & Anthony Schaller President & CTO George Reznik CFO & Corporate Secretary John Tse Health, Medical and Director VP, Commercial Development • • 24 years experience in healthcare innovation Inventor of VELScope, a market leading
Slide 12: Financial and Capitalization Table
Financial and Capitalization Table Financial Position at Capitalization at June 30, 2025 August 14, 2025 Shares Outstanding: 119,977,735 Cash: CDN$9.4M Warrants Outstanding: 22,885,391 Adjusted Working Capital: CND$8.9M Options Outstanding: 12,936,945 Total Assets: CDN$10.8M (includes 5,823,000 opti
Slide 13: Competitive Advantage and Massive Global Market Opportunity
Leading the Digital Health Paradigm Shift Competitive Multiple Regulatory Expanding Advantage Solutions Massive Applications Framework Accurate Strep A Global Consumer Wellness Health Canada COVID-19 Quick FDA Conjunctivitis Market Medical Professional Cost efficient Other Medical Opportunity Condit
Slide 14: Thank you
Thank you Contact: investors@light.ai Confidential - Property of Light AI Inc. 14 CBOE CA: ALGO FSE: 0HC OTCQB: OHCFF